Bernhard Resch1, Stefan Kurath-Koller2, Monika Eibisberger2, Werner Zenz3. 1. Research Unit for Neonatal Infectious Diseases and Epidemiology, Division of Neonatology, Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria. bernhard.resch@medunigraz.at. 2. Research Unit for Neonatal Infectious Diseases and Epidemiology, Medical University of Graz, Graz, Austria. 3. Research Unit for Infectious Diseases and Vaccinology, Division of General Pediatrics, Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria.
Abstract
BACKGROUND: Respiratory morbidity of former preterm infants and especially those with bronchopulmonary dysplasia (BPD) is high during infancy and early childhood. DATA SOURCES: We performed a review based on a literature search including EMBASE, MEDLINE, and CINAHL databases to identify all relevant papers published in the English and German literature on influenza and respiratory syncytial virus infection associated with preterm infant, prematurity, and BPD between 1980 and 2014. RESULTS: Recurrent respiratory symptoms remain common at preschool age, school age and even into young adulthood. Acute viral respiratory tract infections due to different pathogens cause significant morbidity and necessitate rehospitalizations during the first years of life. Influenza virus infection plays a minor role compared to respiratory syncytial virus (RSV) associated respiratory tract infection during infancy and early childhood. Nevertheless, particular morbidity to both viruses is high. CONCLUSIONS: The particular burden of both viral diseases in preterm infants is dominated by RSV and its associated rehospitalizations during the first two years of life. Prophylactic measures include vaccination against influenza virus of family members and caregivers and active immunization starting at the age of 6 months, and monthly injections of palivizumab during the cold season to avoid severe RSV disease and its sequelae.
BACKGROUND:Respiratory morbidity of former preterm infants and especially those with bronchopulmonary dysplasia (BPD) is high during infancy and early childhood. DATA SOURCES: We performed a review based on a literature search including EMBASE, MEDLINE, and CINAHL databases to identify all relevant papers published in the English and German literature on influenza and respiratory syncytial virus infection associated with preterm infant, prematurity, and BPD between 1980 and 2014. RESULTS: Recurrent respiratory symptoms remain common at preschool age, school age and even into young adulthood. Acute viral respiratory tract infections due to different pathogens cause significant morbidity and necessitate rehospitalizations during the first years of life. Influenzavirus infection plays a minor role compared to respiratory syncytial virus (RSV) associated respiratory tract infection during infancy and early childhood. Nevertheless, particular morbidity to both viruses is high. CONCLUSIONS: The particular burden of both viral diseases in preterm infants is dominated by RSV and its associated rehospitalizations during the first two years of life. Prophylactic measures include vaccination against influenza virus of family members and caregivers and active immunization starting at the age of 6 months, and monthly injections of palivizumab during the cold season to avoid severe RSV disease and its sequelae.
Authors: Janyra A Espinoza; Karen Bohmwald; Pablo F Céspedes; Roberto S Gómez; Sebastián A Riquelme; Claudia M Cortés; Javier A Valenzuela; Rodrigo A Sandoval; Floria C Pancetti; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis Journal: Proc Natl Acad Sci U S A Date: 2013-05-06 Impact factor: 11.205
Authors: K N Subramanian; L E Weisman; T Rhodes; R Ariagno; P J Sánchez; J Steichen; L B Givner; T L Jennings; F H Top; D Carlin; E Connor Journal: Pediatr Infect Dis J Date: 1998-02 Impact factor: 2.129
Authors: Johannes G Liese; Eva Grill; Birgit Fischer; Irmgard Roeckl-Wiedmann; David Carr; Bernd H Belohradsky Journal: Eur J Pediatr Date: 2003-03-01 Impact factor: 3.183
Authors: J-B Gouyon; J-C Rozé; C Guillermet-Fromentin; I Glorieux; L Adamon; M DI Maio; T Miloradovich; D Anghelescu; D Pinquier; B Escande; C Elleau Journal: Epidemiol Infect Date: 2012-06-15 Impact factor: 4.434
Authors: Carl T D'Angio; Claire P Wyman; Ravi S Misra; Jessica L Halliley; Hongyue Wang; Julianne E Hunn; Caitlin M Fallone; F Eun-Hyung Lee Journal: Vaccine Date: 2017-08-12 Impact factor: 3.641
Authors: Bernard Thébaud; Kara N Goss; Matthew Laughon; Jeffrey A Whitsett; Steven H Abman; Robin H Steinhorn; Judy L Aschner; Peter G Davis; Sharon A McGrath-Morrow; Roger F Soll; Alan H Jobe Journal: Nat Rev Dis Primers Date: 2019-11-14 Impact factor: 52.329
Authors: Jeong Eun Shin; Haerin Jang; Jung Ho Han; Joonsik Park; Soo Yeon Kim; Yoon Hee Kim; Ho Seon Eun; Soon Min Lee; Kook In Park; Myung Hyun Sohn; Min Soo Park; Kyung Won Kim Journal: Sci Rep Date: 2022-05-09 Impact factor: 4.996
Authors: Joseph M Collaco; Brianna C Aoyama; Jessica L Rice; Sharon A McGrath-Morrow Journal: Expert Rev Respir Med Date: 2021-06-17 Impact factor: 3.772
Authors: Belén Fernández Colomer; Manuel Sánchez-Luna; Concepción de Alba Romero; Ana Alarcón; Ana Baña Souto; Fátima Camba Longueira; María Cernada; Zenaida Galve Pradell; María González López; M Cruz López Herrera; Carmen Ribes Bautista; Laura Sánchez García; Elena Zamora Flores; Adelina Pellicer; Clara Alonso Díaz; Cristina Herraiz Perea; Dolores Sabina Romero Ramírez; Isabel de Las Cuevas Terán; Isabel Pescador Chamorro; José Luis Fernández Trisac; Luis Arruza Gómez; Luis Miguel Cardo Fernández; Mª Jesús García García; Marta Nicolás López; Miryam Hortelano López; Mónica Riaza Gómez; Natalio Hernández González; Raquel González Sánchez; Sílvia Zambudio Sert; Susana Larrosa Capacés; Vanesa Matías Del Pozo Journal: Front Pediatr Date: 2020-10-23 Impact factor: 3.418